| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 12, 2025 | KNSA Kiniksa Pharmaceuticals International, Plc | Megna Michael R | Chief Accounting Officer | Sell | 9,051 | $22.45 | $203,194.95 | -25.4% | +32.3% | +104.8% | |
| Mar 12, 2025 | EBS Emergent Biosolutions Inc. | Zoon Kathryn C62 | Director | Sell | 10,000 | $5.73 | $57,300.00 | -18.4% | +9.8% | +32.2% | |
| Mar 12, 2025 | KNSA Kiniksa Pharmaceuticals International, Plc | Ragosa Mark | Chief Financial Officer | Sell | 36,372 | $22.25 | $809,277.00 | -61.3% | +32.3% | +104.8% | |
| Mar 12, 2025 | EOLS Evolus, Inc. | Parschauer Karah Herdman77 | Director | Sell | 12,888 | $12.99 | $167,465.38 | -28.6% | -26.5% | -63.4% | |
| Mar 12, 2025 | EBS Emergent Biosolutions Inc. | Fowler Neal Franklin | Director | Sell | 35,000 | $5.83 | $204,050.00 | -25.7% | +9.8% | +32.2% | |
| Mar 11, 2025 | ZTS Zoetis Inc. | Reed Willie M55 | Director | Sell | 1,210 | $166.14 | $201,029.40 | -9.7% | +0.1% | -27.1% | |
| Mar 11, 2025 | HIMS Hims & Hers Health, Inc. | Becklund Irene | Pao | Sell | 2,203 | $34.77 | $76,598.31 | -50.0% | +63.8% | -25.4% | |
| Mar 11, 2025 | COLL Collegium Pharmaceutical, Inc | Tupper Colleen45 | EVP &Chief Financial Officer | Sell | 10,445 | $30.01 | $313,412.67 | -5.9% | +1.5% | +18.8% | |
| Mar 11, 2025 | DERM Journey Medical Corp | Maraoui Claude | President &CEO | Sell | 49,271 | $5.01 | $246,847.71 | -2.4% | +39.0% | +58.8% | |
| Mar 11, 2025 | ELAN Elanco Animal Health Inc | Kurzius Lawrence Erik77 | Director | Buy | 20,000 | $10.55 | $211,000.00 | +10.4% | +38.6% | +133.6% | |
| Mar 10, 2025 | UTHR United Therapeutics Corp | Benkowitz Michael47 | President And COO | Sell | 2,000 | $320.09 | $640,183.75 | -25.1% | +3.3% | +68.7% | |
| Mar 10, 2025 | ETST Earth Science Tech, Inc. | Tabraue Mario Guillermo | COO | Buy | 40,000 | $0.14 | $5,600.00 | +0.3% | - | - | |
| Mar 10, 2025 | PBH Prestige Consumer Healthcare Inc. | Fritz Mary Beth57 | SVP Quality &Regulatory | Sell | 1,678 | $90.00 | $151,020.00 | -8.9% | -1.4% | -24.7% | |
| Mar 10, 2025 | KNSA Kiniksa Pharmaceuticals International, Plc | Tessari Eben | Chief Operating Officer | Sell | 12,409 | $21.06 | $261,333.54 | -13.9% | +45.4% | +125.4% | |
| Mar 10, 2025 | ZTS Zoetis Inc. | Lagano Roxanne70 | Executive Vice President | Sell | 326 | $170.00 | $55,420.00 | -2.0% | -4.2% | -29.9% | |
| Mar 10, 2025 | VRNO Verano Holdings Corp. | McDermott Edward Aloysious III | Chief Operating Officer | Sell | 7,692 | $0.65 | $5,000.57 | -5.4% | - | - | |
| Mar 10, 2025 | VRNO Verano Holdings Corp. | Weiss Darren Henry | President | Sell | 22,922 | $0.65 | $14,901.59 | -3.7% | - | - | |
| Mar 10, 2025 | VRNO Verano Holdings Corp. | Spreckman David | Chief Marketing Officer | Sell | 5,462 | $0.65 | $3,550.85 | -3.7% | - | - | |
| Mar 10, 2025 | VRNO Verano Holdings Corp. | Miles Aaron Nathaniel | Chief Investment Officer | Sell | 4,642 | $0.65 | $3,017.76 | -2.2% | - | - | |
| Mar 10, 2025 | VRNO Verano Holdings Corp. | Kalesnik Laura Marie | See Remarks | Sell | 4,667 | $0.65 | $3,034.02 | -2.2% | - | - | |
| Mar 10, 2025 | VRNO Verano Holdings Corp. | Tipton John Allen | See Remarks | Sell | 25,838 | $0.65 | $16,797.28 | -0.8% | - | - | |
| Mar 10, 2025 | PRGO Perrigo Co Plc | Janish Ronald Craig61 | EVP, Gbl Ops &Sc &CTO | Sell | 7,800 | $27.44 | $214,032.00 | -18.8% | -4.6% | -63.2% | |
| Mar 7, 2025 | DVAX Dynavax Technologies Corp | Novack David F73 | President &COO | Sell | 32,764 | $14.39 | $471,473.96 | -59.7% | -30.9% | - | |
| Mar 7, 2025 | ANIP Ani Pharmaceuticals Inc | Davis Krista45 | SVP, Chief Hr Officer | Sell | 1,000 | $60.86 | $60,860.00 | -1.5% | -1.2% | +22.1% | |
| Mar 7, 2025 | COLL Collegium Pharmaceutical, Inc | Tupper Colleen45 | EVP &Chief Financial Officer | Sell | 3,453 | $30.00 | $103,591.05 | -1.0% | +2.0% | +28.9% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.